Companies: 48,687 Total Market Cap: 127290957528967.79

Agilent Technologies

NYSE: A
Healthcare Diagnostics & Research
Rank #663
Market Cap 30.97 B
Volume 1.21 M
Price 108.63
Change (%) 2.04%
Country or region United States United States

Agilent Technologies's latest marketcap:

30.97 B

As of May 4, 2025, Agilent Technologies's market capitalization has reached $30.97 B. According to our data, Agilent Technologies is the 663th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 30.97 B
Revenue (ttm) 6.53 B
Net Income (ttm) 1.26 B
Shares Out 285.10 M
EPS (ttm) 4.36
Forward PE 19.17
Ex-Dividend Date April 1, 2025
Earnings Date May 28, 2025
Market Cap Chart
Data Updated: May 4, 2025

Agilent Technologies's yearly market capitalization.

Agilent Technologies has seen its market value drop from $34.40 B to $30.30 B since 1999, representing a total decrease of 11.92% and an annual compound decline rate (CAGR) of 0.50%.
Date Market Cap Change (%)
April 25, 2025 $30.30 B -21.02%
December 31, 2024 $38.37 B -5.82%
December 29, 2023 $40.74 B -8.06%
December 30, 2022 $44.31 B -8.1%
December 31, 2021 $48.21 B 32.61%
December 31, 2020 $36.36 B 37.4%
December 31, 2019 $26.46 B 23.15%
December 31, 2018 $21.49 B -0.67%
December 29, 2017 $21.63 B 47.57%
December 30, 2016 $14.66 B 5.55%
December 31, 2015 $13.89 B 1.17%
December 31, 2014 $13.73 B -27.66%
December 31, 2013 $18.98 B 33.22%
December 31, 2012 $14.24 B 17.14%
December 30, 2011 $12.16 B -15.56%
December 31, 2010 $14.40 B 32.87%
December 31, 2009 $10.84 B 97%
December 31, 2008 $5.50 B -59.69%
December 31, 2007 $13.65 B -3.81%
December 29, 2006 $14.19 B -13.76%
December 30, 2005 $16.45 B 40.21%
December 31, 2004 $11.73 B -15.73%
December 31, 2003 $13.92 B 65.99%
December 31, 2002 $8.39 B -35.63%
December 31, 2001 $13.03 B -47.46%
December 29, 2000 $24.80 B -27.91%
December 31, 1999 $34.40 B

Company Profile

About Agilent Technologies, Inc.

Agilent Technologies, Inc. delivers application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. Founded in 1999 and headquartered in Santa Clara, California, the company serves its customers through direct sales, distributors, resellers, manufacturer's representatives, and e-commerce.

Business Segments

  • Life Sciences and Applied Markets

    This segment offers a comprehensive portfolio of analytical instruments and solutions, including:

    • Liquid and gas chromatography systems with mass spectrometry capabilities
    • Spectroscopy instruments (ICP-MS, AA, MP-AES, ICP-OES, Raman)
    • Laboratory software, automation systems, and information management tools
    • Consumables such as GC/LC columns, sample preparation products, and custom chemistries
  • Diagnostics and Genomics

    This segment provides solutions for:

    • Genomics research and biomolecular analysis
    • Pathology and companion diagnostics
    • Cell analysis through plate-based assays, flow cytometers, and imaging systems
    • Contract manufacturing and R&D services
  • Agilent CrossLab

    This segment delivers comprehensive services including:

    • Instrument maintenance, repairs, and installations
    • Training, compliance support, and consulting
    • Software as a Service (SaaS) and asset management solutions
Frequently Asked Questions

As of May 4, 2025, Agilent Technologies (including the parent company, if applicable) has an estimated market capitalization of $30.97 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Agilent Technologies global market capitalization ranking is approximately 663 as of May 4, 2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region United States
Founded 1999
IPO Date November 18, 1999
Employees 17,900
CEO Padraig McDonnell
Sector Healthcare
Industry Diagnostics & Research
Address 5301 Stevens Creek Boulevard
Santa Clara, California 95051
United States
People Also Watch
FRA-SSH
66.64 2.99%
HOSE-KSB
0.60 2.99%
KOSDAQ-171120
1.66 2.99%
NSE-VISHNUINFR
2.20 2.99%